ANXA2 and lung carcinoma: The displacement of S100A10 from annexin A2 by DLC1, a Rho GTPase-activating protein (RhoGAP) that functions as a tumor suppressor, results in the attenuation of plasminogen activation and impaired invasion of A549 lung cancer cells [87].